Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.
Astellas Pharma
45 followers
Tilray
19 followers
Knight Therapeutics
1 follower
AstraZeneca
463 followers
Bayer
385 followers
Bristol-Myers Squibb
275 followers
UCB
68 followers
NYU Langone Health
34 followers
Perrigo
17 followers
West Pharmaceutical Services
10 followers
Dechra Pharmaceuticals
9 followers
Explore companies